PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy. Electronic address: nicola.fazio@ieo.it.\', \'Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy; Molecular Medicine Program, University of Pavia, Pavia, Italy.\', \'Division of Medical Oncology Mayo Clinic, Rochester, MN, USA.\', \'Medical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain.\', \'Department of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands.\', \'Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.\', \'Department of Hematology and Oncology Mayo Clinic, Phoenix, AZ, USA.\', \'Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.\', \'1st Department of Propaedeutic Internal Medicine, Endocrine Unit, National and Kapodistrian, University of Athens, 11527 Athens, Greece.\', \'Oncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.\', \'Neuroendocrine Tumors Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy.\', \'Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.\', \'Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(21)00404-410.1016/j.ejca.2021.06.029
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 34298375
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34298375>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34298375>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all